• linkedin
  • Increase Font
  • Sharebar

    A promising target for immunotherapy?


    Stable patient-derived xenograft models and cell lines of upper tract urothelial carcinoma have been developed and offer utility for drug screening as a personalized medicine approach.


    You must be signed in to leave a comment. Registering is fast and free!

    All comments must follow the ModernMedicine Network community rules and terms of use, and will be moderated. ModernMedicine reserves the right to use the comments we receive, in whole or in part,in any medium. See also the Terms of Use, Privacy Policy and Community FAQ.

    • No comments available